Lukas Havla
Overview
Explore the profile of Lukas Havla including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
57
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kunz W, Schuler F, Sommer W, Fabritius M, Havla L, Meinel F, et al.
Invest Radiol
. 2016 Nov;
52(5):302-309.
PMID: 27861231
Objective: The aim of this study was to test the diagnostic value of wavelet-based angiographic reconstruction of CT perfusion data (waveletCTA) to detect cerebral venous sinus thrombosis (CVST) in patients...
2.
Kunz W, Sommer W, Havla L, Dorn F, Meinel F, Dietrich O, et al.
Eur Radiol
. 2016 Oct;
27(6):2657-2664.
PMID: 27722798
Objectives: To determine the detection rate of intracranial vessel occlusions using CT perfusion-based wavelet-transformed angiography (waveletCTA) in acute ischemic stroke patients, in whom single-phase CTA (spCTA) failed to detect an...
3.
Havla L, Schneider M, Thierfelder K, Beyer S, Ertl-Wagner B, Reiser M, et al.
Med Phys
. 2016 Feb;
43(2):702-9.
PMID: 26843234
Purpose: The purpose of this study was to propose and evaluate a new wavelet-based technique for classification of arterial and venous vessels using time-resolved cerebral CT perfusion data sets. Methods:...
4.
Kazmierczak P, Burian E, Eschbach R, Hirner-Eppeneder H, Moser M, Havla L, et al.
PLoS One
. 2015 Sep;
10(9):e0138452.
PMID: 26393949
Objective: To investigate annexin-based optical fluorescence imaging (OI) for monitoring regorafenib-induced early cell death in experimental colon carcinomas in rats, validated by perfusion MRI and multiparametric immunohistochemistry. Materials And Methods:...
5.
Havla L, Schneider M, Thierfelder K, Beyer S, Ertl-Wagner B, Sommer W, et al.
Eur Radiol
. 2015 Mar;
25(10):2937-44.
PMID: 25820479
Objectives: We aimed to develop and evaluate a new method that reliably differentiates between cerebral arteries and veins using voxel-wise CT-perfusion-derived parameters. Materials And Methods: Fourteen consecutive patients with suspected...
6.
Wavelet-based calculation of cerebral angiographic data from time-resolved CT perfusion acquisitions
Havla L, Thierfelder K, Beyer S, Sommer W, Dietrich O
Eur Radiol
. 2015 Feb;
25(8):2354-61.
PMID: 25716940
Objectives: To evaluate a new approach for reconstructing angiographic images by application of wavelet transforms on CT perfusion data. Methods: Fifteen consecutive patients with suspected stroke were examined with a...
7.
Eschbach R, Fendler W, Kazmierczak P, Hacker M, Rominger A, Carlsen J, et al.
PLoS One
. 2015 Feb;
10(2):e0115543.
PMID: 25668193
Objectives: To investigate a multimodal, multiparametric perfusion MRI / 18F-fluoro-deoxyglucose-(18F-FDG)-PET imaging protocol for monitoring regorafenib therapy effects on experimental colorectal adenocarcinomas in rats with immunohistochemical validation. Materials And Methods: Human...
8.
Thierfelder K, Havla L, Beyer S, Ertl-Wagner B, Meinel F, von Baumgarten L, et al.
Invest Radiol
. 2015 Jan;
50(5):361-5.
PMID: 25591128
Objective: The objective of this study was to develop a new method of displaying dynamic cerebral computed tomographic (CT) angiography (CTA) data sets in which the time delay to maximum...
9.
Havla L, Peller M, Cyran C, Nikolaou K, Reiser M, Dietrich O
J Comput Assist Tomogr
. 2014 Oct;
39(1):134-9.
PMID: 25279847
The purpose of this study was to evaluate a new dual-energy computed tomographic postprocessing approach on the basis of the transformation of dual-energy radiodensity data into polar coordinates. Given 2...
10.
Sterzik A, Paprottka P, Zengel P, Hirner H, Rosspunt S, Eschbach R, et al.
Acta Radiol
. 2014 Mar;
56(3):294-303.
PMID: 24609871
Background: Novel anti-angiogenic treatments are increasingly complementing established cancer therapy strategies in head and neck tumors. Contrast-enhanced magnetic resonance imaging (MRI) can be applied for early and non-invasive therapy monitoring...